Dynamics of cell-free DNA in predicting response in adult diffuse glioma on chemoradiotherapy
- 19 September 2022
- journal article
- research article
- Published by Elsevier in Cancer Genetics
- Vol. 268-269, 55-63
Abstract
No abstract availableKeywords
Funding Information
- Dr. Ram Manohar Lohia Institute of Medical Sciences
- University Grants Commission (NOV-2017-343185)
This publication has 28 references indexed in Scilit:
- Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cordProceedings of the National Academy of Sciences, 2015
- Template for Reporting Results of Biomarker Testing of Specimens From Patients With Tumors of the Central Nervous SystemArchives of Pathology & Laboratory Medicine, 2015
- Circulating tumor DNA as a non‐invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor typesMolecular Oncology, 2014
- Gliomas and the vascular fragility of the blood brain barrierFrontiers in Cellular Neuroscience, 2014
- Circulating cell free DNA: Preanalytical considerationsClinica Chimica Acta, 2013
- Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNANature, 2013
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast CancerNew England Journal of Medicine, 2013
- Detection of IDH1 mutation in the plasma of patients with gliomaNeurology, 2012
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working GroupJournal of Clinical Oncology, 2010
- Serum DNA can define tumor-specific genetic and epigenetic markers in gliomas of various gradesNeuro-Oncology, 2010